Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache
Clinical Study to Evaluate Efficacy of New Paracetamol Formulation Compared to Ibuprofen in Headache
The purpose of this multi-center study is to assess the efficacy of headache relief of new
 paracetamol/caffeine formulation compared to placebo and ibuprofen in episodic tension-type
 headache (ETTH).
Inclusion Criteria:

 -  Participants in good general health, and with diagnosis of ETTH with following
 conditions:

 1. number of days with the condition is historically greater than or equal to two
 per month;

 2. severity of headaches is historically at least moderate;

 3. duration of headaches is historically more than or equal to 4 hours, if
 untreated.

 Exclusion Criteria:

 -  Participant with known or suspected hypersensitivity, allergy, intolerance or
 contraindication to the use of any of the study medications

 -  Participant has chronic tension type headache, psychiatric disease or a significant
 cognitive disorder, or any chronic pain disorder.

 -  Participant currently taking or has taken medications or herbal supplements within the
 three months that are likely to interfere with the validity of subject-rated
 assessments.